2022
DOI: 10.3892/ol.2022.13275
|View full text |Cite
|
Sign up to set email alerts
|

NPTX1 inhibits pancreatic cancer cell proliferation and migration and enhances chemotherapy sensitivity by targeting RBM10

Abstract: Pancreatic cancer (PC), one of the deadliest diseases worldwide, has exhibited an increasing incidence rate in recent years. The present study aimed to explore the biological mechanism of PC. Therefore, the expression levels of neuronal pentraxin 1 (NPTX1) and RNA-binding protein 10 (RBM10) were detected in PC cell lines using reverse transcription-quantitative PCR (RT-qPCR) and western blot analyses prior to or following NPTX1 and RBM10 overexpression. Additionally, the proliferative ability of PANC-1 and BxP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 37 publications
1
4
0
Order By: Relevance
“…Our transcriptomic data align with existing studies that have identified genes like NPTX1, TRIM31, and CD82/KAI1 as potential therapeutic targets in various cancers [25][26][27][28][29][30][31][32][33]. NPTX1 has been implicated in inhibiting tumor growth across multiple types of cancer, acting through distinct signaling pathways.…”
Section: Promising Effects Of Upregulated Transcripts On Tumor Growth...supporting
confidence: 83%
“…Our transcriptomic data align with existing studies that have identified genes like NPTX1, TRIM31, and CD82/KAI1 as potential therapeutic targets in various cancers [25][26][27][28][29][30][31][32][33]. NPTX1 has been implicated in inhibiting tumor growth across multiple types of cancer, acting through distinct signaling pathways.…”
Section: Promising Effects Of Upregulated Transcripts On Tumor Growth...supporting
confidence: 83%
“…NPTX1 gene encodes the neuronal pentraxin 1, a member of the pentraxins family [ 31 ]. Recently, NPTX1 has been found to have decreased expression in diverse cancers [ 32 , 33 ], but its expression and impact in melanoma has not been defined yet. In this study, we discovered that circRPS5 knockdown could reduce NPTX1 expression.…”
Section: Discussionmentioning
confidence: 99%
“…According to the related studies on the three candidate target genes, we found that SLC16A6 is a gene encoding monocarboxylic acid transporter 7, which is mainly related to lipid metabolism and length of zebrafish and human height (Karanth & Schlegel, 2018), but has not been related to the regulation of tumor cell proliferation and apoptosis. However, the functional mechanisms of DKK1 and NPTX1 in the regulation of tumor cell proliferation and apoptosis have been extensively proven (Glinka et al, 1998; Ren et al, 2013; Wang, Wang, et al, 2018; Wu et al, 2022; Zhao et al, 2018), and they seem to be more like the target genes of miR‐148a‐3p. Therefore, the regulatory effects of DKK1 and NPTX1 on the proliferation capacity of IGF‐GFs were preliminarily explored by cck‐8 experiment.…”
Section: Discussionmentioning
confidence: 99%
“…The structure of penetrins is very conserved in vertebrates, and they also have high homology sequences in phylogenetic distant species. Several lines of evidence have shown that NPTX1 exerts inhibitory effects on proliferation of different types of cancer cells, such as pancreatic cancer (Wu et al, 2022), breast cancer (Ye et al, 2021), head and neck cancer (Lu et al, 2020), hepatocellular carcinoma (Zhao et al, 2019), and colon cancer (Peng et al, 2018). In addition, previous studies have shown that NPTX1 acts as a target of different noncoding RNAs, including miRNAs.…”
Section: Discussionmentioning
confidence: 99%